BMJ  2007;334:1020 (19 May), doi:10.1136/bmj.39212.685637.3A

Letters

beta blockers

Misuse of confidence intervals threatens conclusions

The first 100% of the full text of this article appears below.

The data presented in table 1 of Ong's review leave considerable uncertainty about whether atenolol is better or worse than other beta blockers.1 The confidence intervals for the results on other beta blockers are wide (as fewer patients have been studied), and the test for interaction shows that the relative risk for atenolol, compared with other beta blockers, for stroke is 1.05 (95% confidence interval 0.26 to 4.17), for myocardial infarction 1.22 (0.91 to 1.63), and for total mortality 1.21 (0.95 to 1.14). All of these confidence intervals include the possibility of no difference, and for stroke the results are compatible with atenolol being four times better or four times worse than other beta blockers. It is very misleading to draw conclusions based on whether significance is achieved with either treatment alone.2

Christopher J Cates, general practitioner

Manor View Practice, Bushey WD23 2NN

chris.cates@nhs.net


Competing interests: None declared.

  1. Ong HT. beta blockers in hypertension and cardiovascular disease. BMJ 2007;334:946-9. (5 May.)[Free Full Text]
  2. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326:219.[Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

beta blockers in hypertension and cardiovascular disease
H T Ong
BMJ 2007 334: 946-949. [Extract] [Full Text] [PDF]

Statistics Notes: Interaction revisited: the difference between two estimates
Douglas G Altman and J Martin Bland
BMJ 2003 326: 219. [Extract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ